Corruption: A Lesson for Tomorrow’s Professionals

Corruption: A Lesson for Tomorrow’s Professionals

  Guest speaking on May 6, 2014 at Fordham University. “Contemporary Issues in Forensic Accounting.” I shared with the students my reflections on international sales, both before and during cooperation, and detailed my thought process as to how I “rationalized bribery.” My hope is that by sharing my perspective with tomorrow’s business professionals, that they might(…)

Rationalizing Risk: Compliance as “Bonus Prevention”

Rationalizing Risk: Compliance as “Bonus Prevention”

As part of my series on “Rationalizing Bribery,” I now turn to the issue of personal incentive compensation. As tweeted by Ben DiPietro, @BenDiPietro1, Wall Street Journal Reporter, during my interview at the Dow Jones Global Compliance Symposium (DJGCS) on April 23, 2014 “I knew (what) I was doing was wrong but rationalized the risk.” I(…)

Rationalizing Bribery: A Perfect Storm from the Field of International Sales.

Rationalizing Bribery: A Perfect Storm from the Field of International Sales.

On April 23, 2014 I was interviewed by Chris Matthews, Wall Street Journal Reporter, at the Dow Jones Global Compliance Symposium, in a keynote interview entitled “Informing on Bribery.” The session started by discussing elements of my cooperation with US law enforcement, including my disclosures to the Department of Justice and FBI concerning overseas corruption(…)

GSK, “Free Samples,” and a New Business Model.

On April 16th, 2014 Hester Plumridge and Christopher M. Matthews, Wall Street Journal, reported that GlaxoSmithKline (GSK) is investigating claims that its employees bribed doctors “in Jordan and Lebanon by offering perks such as flexible travel arrangements and free samples that doctors could sell on…” (for the full article, link here).  GSK, as reported in the(…)